The German pharmaceutical-and-agricultural group said the acquisition would complement its drug pipeline and leverage its ophthalmology footprint.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Date:
More like thisRelated
US Center for SafeSport releases summer safety checklist for parents
The U.S. Center for SafeSport has released a...
5 science-backed pricing tips from the U.K.’s top marketing podcast
In 2007, Coulter and Coulter showed two advertisements to...
Chet Hanks Moves to Nashville to Pursue Country Music
Chet Hanks is fully embracing life in Nashville —...
Energy & Utilities Roundup: Market Talk
Find insight on Equinor, Ampol, Keppel Infrastructure Trust and...